QNZ46 NEW

Price	$29	$48	$98
Package	5mg	10mg	25mg

Supply Ability:	10g
Update Time:	2026-05-11

Product Details

Product Name: QNZ46	CAS No.: 1237744-13-6
Purity: 99.65%	Supply Ability: 10g
Release date: 2026/05/11

Product Introduction

Bioactivity

Name	QNZ46
Description	QNZ46 is a non-competitive antagonist of NMDA receptors, selectively targeting NR2C/NR2D subunits.
Kinase Assay	Biochemical filter-binding assays for detection of FGFR phosphorylation activities : Reaction mixtures contains 8 mM Tris-HCl (pH 7.5), 10 mmol/L HEPES, 5 mM dithiothreitol, 10 μM ATP, 0.5 μCi 33P-ATP, 10 mM MnCl2, 150 mM NaCl, 0.01% Triton X-100, 4% dimethyl sulfoxide, 0.05 mg/mL poly(Glu:Tyr) (4:1, average molecular weight of 20–50 kDa), and 7.5, 7.5, and 16 ng of FGFR1, FGFR3, and FGFR4, respectively, and are incubated at room temperature for 30 minutes followed by termination with 10% H3PO4. The reaction mixtures are transferred to 96-well MAFB filter plates that are washed 3 times with 0.5% H3PO4. After air-drying, the plates are read with a Trilux reader.
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	DMSO : 4.44 mg/mL (10.01 mM), Sonication is recommended.
Keywords	QNZ-46 \| QNZ46 \| QNZ 46 \| NR2D \| NR2C \| NR2A \| Ionotropic glutamate receptors \| Inhibitor \| inhibit \| iGluR
Inhibitors Related	Indole-2-carboxylic acid \| Urethane \| Decanoic Acid \| N-Methylsarcosine \| L-Glutamic acid \| N,N-Dimethylglycine hydrochloride \| Kynurenic acid \| L-Phenylalanine \| glycine \| L-Glutamic acid monosodium salt \| Memantine \| Memantine hydrochloride
Related Compound Libraries	Pain-Related Compound Library \| Bioactive Compound Library \| Anti-Neurodegenerative Disease Compound Library \| Antidepressant Compound Library \| Membrane Protein-targeted Compound Library \| Anti-Parkinson's Disease Compound Library \| Glutamine Metabolism Compound Library \| Neurotransmitter Receptor Compound Library \| Inhibitor Library \| Neuroprotective Compound Library \| Bioactive Compounds Library Max \| Ion Channel Targeted Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.